Figure 5 indicated that the TMB of patients with TP53, TTN, RYR2, LRP1B, FSIP2, and SPTA1 mutations was significantly higher than that of patients without these mutations for both NSCLC and SCLC. The gene discussed is RYR2; the disease is small cell lung carcinoma.